Daiichi Sankyo Co Ltd - Company & Market Research Reports

Home /
Companies /
Daiichi Sankyo Co Ltd

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 113
Cardiovascular Drugs 84
Vaccines 47
Drug Discovery 40
Central Nervous System Drugs 40
Hematological Drugs 35
Pharmaceuticals 33
Endocrine and Metabolic Disorders Drugs 30
Immune Disorders Drugs 27
Leukemia Drugs 26
Musculoskeletal Disorders Drugs 26
Genomics 25
Infectious Diseases Drugs 24
Analgesics 24
Clinical Trials 24
Biopharmaceuticals 22
Contrast Media 19
Skin Cancer Drugs 17
Oncology 16
Biotechnology 15
Women's Health 14
Infusions and Injectables 14
Antibiotics 14
Lung Cancer Drugs 13
Enzymes 13
Breast Cancer Drugs 12
Alzheimer's Disease Drugs 12
Diabetes Drugs 11
Liver and Kidney Disorders Drugs 11
Diagnostics 10
Hematology 10
Gastrointestinal Drugs 10
Brain Cancer Drugs 9
Respiratory Drugs 9
Allergy and Immunology 8
Healthcare Services 8
Biosimilars and Biosuperiors 8
Pharmaceutical Manufacturing 8
Colon Cancer Drugs 7
Cardiology 7
Ultrasound 6
Urological Disorders Drugs 6
Animal Pharmaceuticals 5
Optical Disorders Drugs 5
Neurology 5
Lymphoma Drugs 5
Infectious Disease Testing 5
Managed Care 5
Stem Cells 5
Thyroid Cancer Drugs 5
Pharmaceutical Intermediates 4
Pulmonary Medicine 4
Liver Cancer Drugs 4
Ovarian Cancer Drugs 4
Cervical Cancer Drugs 4
In Vitro Diagnostics 4
Medical Devices 4
Drug Delivery 4
Gastroenterology 4
Dermatological Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Transdermal and Transmucosal Drug Delivery 3
Pancreatic Cancer Drugs 3
Pediatrics 3
HIV/AIDS Drugs 3
Company Reports 2
Therapeutic Area 2
Urology and Nephrology 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Blood Banking 2
Anesthetic Drugs 2
Needles and Syringes 2
Neurology Devices 2
Over the Counter (OTC) Drugs 2
Nuclear Medicine and Radiopharmacology 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Anti-Obesity Drugs 2
Palliative Care 2
Bronchitis Drugs 2
Patient Monitoring Equipment 1
Pharmacoeconomics 1
Proteomics 1
Medical Imaging 1
Hospital Information Systems 1
Coagulation and Hemostasis Testing 1
Healthcare 1
Dental 1
Magnetic Resonance Imaging (MRI) 1
Radiography 1
Optical 1
Hospital Management 1
Biomarkers 1
Dermatology 1
Surgical Procedures 1
Molecular Diagnostics 1
Catheters 1
Mental Disorders Drugs 1
Uterine Cancer Drugs 1
Other Healthcare Facilities 1
Nanomedicine 1
Laboratory Equipment 1
Endocrinology 1
Acne Drugs 1
Asthma Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

777 Results (Page 28 of 39)
- Relevance
  Sort by

DELYTACT Drug Insight and Market Forecast - 2032

 Report
November 2023
30 Pages
Global

From

€1941EUR$2,200USD£1,700GBP

€2426EUR$2,750USD£2,124GBP

Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034

 Report
February 2024
228 Pages
Global

From

€5611EUR$6,360USD£4,913GBP

€7014EUR$7,950USD£6,142GBP

Hospital Acquired Infection Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

 Report
October 2023
146 Pages
Global

From

€3112EUR$3,528USD£2,725GBP

€3661EUR$4,150USD£3,206GBP

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3661EUR$4,150USD£3,206GBP

Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028

 Report
September 2025
120 Pages
Global

From

€2470EUR$2,800USD£2,163GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032

 Report
November 2023
276 Pages
Global

From

€6705EUR$7,600USD£5,871GBP

€8381EUR$9,500USD£7,339GBP

Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032

 Report
November 2023
353 Pages
Global

From

€6705EUR$7,600USD£5,871GBP

€8381EUR$9,500USD£7,339GBP

Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032

 Report
November 2023
224 Pages
Global

From

€5294EUR$6,000USD£4,635GBP

€6617EUR$7,500USD£5,794GBP

Acute Myeloid Leukemia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3961EUR$4,490USD£3,469GBP

Myelodysplastic Syndrome Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3961EUR$4,490USD£3,469GBP

Higher-Risk Chronic Myelomonocytic Leukemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5611EUR$6,360USD£4,913GBP

€7014EUR$7,950USD£6,142GBP

Stem Cell Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
120 Pages
Global

From

€4191EUR$4,750USD£3,670GBP

Pleurodynia Treatment - Global Strategic Business Report

 Report
December 2025
270 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

Vaccine Sales Market Report 2023-2033

 Report
June 2023
364 Pages
Global

From

€4669EUR$5,477USD£3,950GBP

Companion Animal Postoperative Pain Management Therapeutics - Global Strategic Business Report

 Report
December 2025
474 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

Combination Vaccines - Global Strategic Business Report

 Report
December 2025
373 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

Bacterial Vaccines Market - Global Strategic Business Report

 Report
December 2025
490 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

Adenovirus Vaccines Market - Global Strategic Business Report

 Report
December 2025
279 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

Inactivated Vaccines Market - Global Strategic Business Report

 Report
December 2025
468 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

Mumps Vaccines Market - Global Strategic Business Report

 Report
December 2025
288 Pages
Global

From

€5161EUR$5,850USD£4,519GBP

777 Results (Page 28 of 39)
- 1
- 26
- 27
- 28
- 29
- 30

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.